Article
Low-grade glioma: A rare second tumor in retinoblastoma survivors.
Pediatric blood & cancer - 1 Feb 2021
Dalvi Nagma, Kleinerman Ruth A, Epelman Sidnei, Abramson David H, Dunkel Ira J
Abstract excerpt
Retinoblastoma survivors with a germline RB1 mutation are at elevated risk for secondary (nonocular) malignancy, but their risk for low-grade glioma (LGG) is unknown. We performed a retrospective review of the Memorial Sloan Kettering Cancer Center and the NCI databases that revealed that three of the 837 5-year survivors of hereditary retinoblastoma were diagnosed with an LGG and a fourth patient (but unilateral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
